When I started building the BestDosage directory, I expected maybe 200-300 ketamine clinics nationwide. We found 1,435. In three years, ketamine therapy went from a niche treatment offered by a handful of pioneering psychiatrists to a national industry.
That explosive growth is both exciting and concerning. Exciting because ketamine represents the most significant breakthrough in depression treatment in decades. Concerning because not every clinic offering ketamine infusions has the psychiatric expertise to manage what happens after the IV drip ends.
Here's what the science says, what the industry doesn't always tell you, and how to find a provider who actually knows what they're doing.
How Ketamine Works — The Mechanism
Traditional antidepressants (SSRIs, SNRIs) work on serotonin and norepinephrine systems. They take 4-8 weeks to reach therapeutic effect because they rely on slow downstream neuroplastic changes. Many patients never respond at all — roughly 30% of major depressive disorder cases are classified as "treatment-resistant."
Ketamine takes a completely different path. It's an NMDA receptor antagonist that blocks glutamate signaling and triggers a rapid cascade of neuroplasticity. Within hours — not weeks — ketamine increases brain-derived neurotrophic factor (BDNF), promotes synaptogenesis (new synaptic connections), and restores neural circuits degraded by chronic depression.
As a chemist, the pharmacology is fascinating. Ketamine doesn't just change your brain chemistry temporarily — it structurally rebuilds neural pathways. The antidepressant effect can outlast the drug's presence in the body by days to weeks, precisely because the changes are architectural, not just chemical.
What the Research Shows
The evidence for ketamine in treatment-resistant depression is among the strongest in modern psychiatry.
A landmark meta-analysis in the American Journal of Psychiatry (PMID: 28493069) pooled data from multiple randomized controlled trials and found that a single subanesthetic dose of intravenous ketamine produced rapid, significant antidepressant effects within 24 hours, with response rates of 50-70% in treatment-resistant patients. For context, these are patients who had failed multiple conventional antidepressants.
A 2019 trial published in the New England Journal of Medicine (PMID: 30726688) led to the FDA approval of esketamine (Spravato), a nasal spray formulation of the S-enantiomer of ketamine, for treatment-resistant depression. The trial demonstrated significant improvement in depression scores compared to placebo when combined with a new oral antidepressant.
For suicidal ideation specifically, a study in The American Journal of Psychiatry (PMID: 29202655) found that ketamine reduced suicidal thoughts within 24 hours — a speed no other available treatment can match.
IV Ketamine vs. Esketamine (Spravato) vs. At-Home Ketamine
This is where it gets nuanced, and where most articles oversimplify.
IV ketamine infusions are the gold standard in research. Administered in a clinical setting over 40-60 minutes at 0.5 mg/kg. Most protocols involve 6 infusions over 2-3 weeks. Cost: $400-$800 per infusion, rarely covered by insurance. This is what the vast majority of clinical trials studied.
Esketamine (Spravato) is the FDA-approved nasal spray — but it must be administered in a certified REMS clinic under observation. It's the S-enantiomer of ketamine (racemic ketamine is what's used in IV clinics). Insurance often covers Spravato when criteria are met. Cost with insurance: $30-$100 per session. Without: $600-$900.
At-home oral/sublingual ketamine (companies like Mindbloom, Joyous, Nue Life) has exploded since 2022. These are prescribed via telehealth and self-administered at home. The research base for oral ketamine is thinner than IV, and bioavailability is significantly lower (17-30% for sublingual vs. 100% for IV). Cost: $150-$300/month.
My honest take: if you have treatment-resistant depression, start with IV ketamine or Spravato in a clinical setting with psychiatric support. At-home ketamine can be appropriate for maintenance after initial clinical treatment, but it should not be your first exposure — you need medical monitoring during those early sessions.
Red Flags at a Ketamine Clinic
With 1,435 clinics mapped, we've seen the full spectrum. Here's what concerns me:
- No psychiatric evaluation before treatment. Ketamine is a psychiatric intervention. If the clinic doesn't assess your mental health history, medication interactions, and contraindications before your first infusion, that's a problem.
- No integration support. The ketamine experience can bring up intense emotions and psychological material. Clinics should offer or refer for psychotherapy integration — not just infuse and discharge.
- Aggressive upselling. "You need 12 sessions minimum" without any assessment of your response after 2-3 sessions is a billing strategy, not medicine.
- No monitoring equipment. Vital signs (blood pressure, heart rate, oxygen saturation) should be monitored continuously during infusion. If you don't see monitoring equipment, leave.
How to Find a Reputable Ketamine Clinic
At BestDosage, we've scored every ketamine clinic in our directory using our 12-category BDS framework. We look at provider credentials (is there a board-certified psychiatrist or anesthesiologist on staff?), patient reviews, pricing transparency, and clinical protocols.
A high BDS score means the clinic has verified credentials, transparent pricing, positive patient outcomes, and a clinical model grounded in the evidence — not just a nurse with an IV and a recliner.
Browse ketamine clinics near you →
I'm Chad. Your chemist.